Zebularine’s stability at both acidic and neutral pH levels, unlike azacytidine and decitabine, is crucial for maintaining long-term DNMT inhibition, and its suitability for regular dosing or continuous intravenous infusion ensures consistent and sustained epigenetic therapy, which is vital for effectively countering lung cancer progression [70]. Here, DNMT1 is linked to lung carcinoma.